FOR PATIENTS · SOURCE READING
Chemotherapy
Source: Hairy Cell Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 23, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated. Cladribine and pentostatin are anticancer drugs commonly used to treat hairy cell leukemia. These drugs may increase the risk of other types of cancer, especially Hodgkin lymphoma and non-Hodgkin lymphoma. Long-term follow-up for second cancers is very important. Bendamustine is another anticancer drug that is being studied to treat hairy cell leukemia.
Learn more about Drugs Approved for Hairy Cell Leukemia.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle